Stankovic Srdjan R. 4
4 · ACADIA PHARMACEUTICALS INC · Filed Nov 23, 2021
Insider Transaction Report
Form 4
Transactions
- Exercise/Conversion
Common Stock
2021-11-19+6,250→ 44,315 total - Sale
Common Stock
2021-11-22$19.01/sh−2,803$53,285→ 41,512 total - Exercise/Conversion
Restricted Stock Units
2021-11-19−6,250→ 6,250 total→ Common Stock (6,250 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F2]The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units.
- [F3]The restricted stock units vest in four equal annual installments beginning 11/19/2019.